How kidney and urinary tract cancers use nutrients, studied during surgery or biopsy
Studies how kidney and urothelial cancers use nutrients, in adults having surgery or biopsy.
Key facts
- Who runs it
- University of Texas Southwestern Medical Center
- Where
- Dallas, United StatesSee the site
- Trial code
- Registry title
- An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
- Status
- Recruiting
- People taking part
- 600 people, planned
- Started
- 30 Sept 2019
- Expected to end
- 30 Sept 2027
- Type of study
- Interventional, 5 groups
- Treatments tested
- 13C-Glucose
- 13C-Acetate
- 13C-Lactate
- 13C-Glutamine
- 13C-Fructose
- Record updated
- 28 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with known or probable kidney or urothelial cancer who need a surgical biopsy or surgery. It studies how these tumors use nutrients.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Known or probable kidney or urothelial cancer seen on imaging, needing a surgical biopsy or removal
- Earlier treatment
- Taking part in other clinical trials is allowed; the study doctor decides case by case
Main reasons for not taking part
- Uncontrolled or poorly controlled diabetes, for people getting a 13C infusion
- Pregnant or breastfeeding
- Cannot have surgery
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patients must have radiographic evidence of known or probable kidney or urothelial cancer requiring surgical biopsy or excision
- Age ≥ 18 years
- Subjects of all races and ethnic origins
- The willingness to sign and ability to understand a written informed consent
- Patients participating in other clinical trials are eligible, and will be evaluated on a case by case basis by the Principal Investigator, Dr. Vitaly Margulis, MD
Who cannot take part
- Uncontrolled or poorly controlled diabetes for patients receiving a 13C infusion
- Not a surgical candidate
- Pregnant or breastfeeding
Where in United States
- University of Texas Southwestern Medical CenterDallas, United StatesContact: Vitaly MargulisTaking people
About the trial
What the trial wants to find out
The purpose of this study is to understand the metabolism of cancers involving the kidney, including renal cell carcinomas and urothelial cell carcinomas, and how kidney cancers use different types of fuel to support tumor growth. This study uses specially labeled nutrient tracers of compounds normally found circulating in the blood. The nutrients (glucose, fructose, glutamine, acetate, and lactate) are also found in common foods. A nutrient tracer will be given to the participants through an intravenous (IV) catheter during surgery or biopsy, and blood will be collected every 30 minutes during the infusion to monitor safety parameters and the nutrient tracers. The investigators will collect a tissue sample after the completion of surgery. Participants not having an infusion will have their tissue collected after surgery or biopsy.
Read full original descriptionShow less
Participation in this study will not change patient care. All patients will receive standard of care treatment as determined by their doctors.
The 5 groups in the trial
- 13C-GlucoseTreatment being tested
- 13C-AcetateTreatment being tested
- 13C-LactateTreatment being tested
- 13C-GlutamineTreatment being tested
- 13C-FructoseTreatment being tested
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
- Plain-language title
- How kidney and urinary tract cancers use nutrients, studied during surgery or biopsyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 28 January 2026